Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Vivalto Sante goes international with expansion into Portugal and Switzerland

Vivalto Sante, the third largest for-profit hospital group in France, is joining the likes of Fresenius, Ramsay and Mediclinic as it becomes the latest member of the highly select club of multinational hospital groups. As well as having bought a chain of three clinics in Switzerland, it is buying Lusiadas Saude, the third largest hospital group in Portugal. CEO Daniel Caille tells HBI that the decision to go international has nothing to do with opportunities for consolidation within the French market drying up.

Going international is hard for hospital groups

Vivalto Sante has taken the brave step of going international. That is a bold decision for a hospital business based in a single European country. Very few have succeeded in doing this and those that have are top players buying top players. We think of Fresenius Helios buying Quiron in Spain, Ramsay buying Generale de Santé in France and then Capio in Sweden, and Mediclinic buying Hirslanden in Switzerland. 

3R buys in Switzerland and looks at France

Naxicap-owned imaging group 3R Réseau Radiologique Romand has bought IRIS Radiologie and is eyeing up France. Germany and Italy are also possibles, HBI hears.

Fresenius looking to split off Helios and merge it with competitor

Germany-based multinational healthcare group Fresenius SE is reportedly leaning towards splitting off hospital branch Fresenius Helios and merging it with a competitor hospital chain in order to grow the business and increase its profitability. A spokesperson for the group tells us any such deal would involve Fresenius SE staying on as majority shareholder.

HBI 2022: M&A may slow in H2, but demand remains strong

“We are about to face a global recession,” conceded Hedley Goldberg, managing director at financial advisory group Rothschild, to a packed out audience at the plenary session on the M&A landscape at HBI 2022. “But it will be an unusual one with high levels of inflation and employment.”

HBI 2022: Lack of debt may hit M&A in second half

M&A deals in health care services such as the bid for British health and beauty retailer and pharmacy chain Boots are coming under threat as market uncertainty, interest rates and inflation soar. Massive deals may fail if debt dries up. This could lead to a further slow-down in M&A activity in the second half of 2022, following a record year 2021.

Building Capacity and Care Pathways through Partnerships

How do governments best build capacity quickly? Through partnerships with the for-profit sector. Using the case study of diagnostic imaging networks in the UK and Nordics this session explores how partnerships enable new care pathways to be created, encompassing digital transformation, workforce development and improved patient experience. What other countries and sectors could this model […]

Find Us